Ovid Therapeutics Inc.
OVID· Nasdaq
Released Mar 11, 2020, before the open
10-K filed Mar 11, 2020, 71 days after period end · 0001564590-20-010108
| Metric | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Net Income | -$16.97M | -$12.90M | -$10.96M | -$7.56M |
| EPS Diluted | -$0.35 | -$0.52 | -$0.45 | -$0.77 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ovid Therapeutics Inc. · CIK 1636651 · Engraved from SEC EDGAR